﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Advanced Pharmaceutical Bulletin</JournalTitle>
      <Issn>2228-5881</Issn>
      <Volume>14</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2024</Year>
        <Month>07</Month>
        <DAY>25</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Anti-Inflammatory Potency of Human Wharton’s Jelly Mesenchymal Stem Cell-Derived Exosomes on L2 Cell Line Induced by Lipopolysaccharides</ArticleTitle>
    <FirstPage>434</FirstPage>
    <LastPage>444</LastPage>
    <ELocationID EIdType="doi">10.34172/apb.2024.027</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Ika Adhani</FirstName>
        <LastName>Sholihah</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-2057-6018</Identifier>
      </Author>
      <Author>
        <FirstName>Anggraini</FirstName>
        <LastName>Barlian</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-0826-3134</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/apb.2024.027</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>05</Month>
        <Day>31</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>01</Month>
        <Day>07</Day>
      </PubDate>
    </History>
    <Abstract>Purpose: At present, therapeutic interventions to treat acute lung injury (ALI) remain largely limited to lung-protective strategies, as no real molecular-driven therapeutic intervention has yet become available. The administration of bacterial lipopolysaccharides (LPS) is known as an inflammatory activator, representing a frequently used model of ALI. This study investigated the biological function of normoxic (21% O2 ) vs. hypoxic conditions (5% O2 ) obtained from human Wharton’s Jelly mesenchymal stem cells (hWJ-MSCs) and discovered that exosomes have the ability to suppress inflammatory responses by specifically targeting TNF-α, IL-1β, IL-6. and identify the toll-like receptor 4 (TLR4) NF-κβ gene expression. Methods: Primer culture hWJ-MSCs characterization with trilineage differentiation and CD markers was conducted. To obtain exosomes, hWJ-MSCs were stimulated with two different oxygen levels: 21% (nor-exo) and 5% (hypo-exo). Then, the L2 cell line was induced with LPS 1 µg/mL. Inflamed-L2 was treated with nor-exo, hypo-exo, and dexamethasone as a positive control. The RNA extracted from treated L2 cells was utilized to examine the gene expression profiles of TLR4 and NF-κβ, and the medium was used to measure tumor necrosis factor α (TNF-α), interleukin (IL)-1β, and IL-6 levels using ELISA. Lastly, proteomic analysis of the exosome using LC/MS-MS was conducted. Results: Nor-exo and hypo-exo can be characterized and can produce higher yields exosomes under hypoxic conditions. The expression of TLR4 and NF-κβ genes and the proinflammatory levels such as IL-6, IL-1β, and TNF-α levels in nor-exo and hypo-exo treatments decreased. Conclusion: Nor-exo and hypo-exo derived from hWJ-MSCs were proven to have anti-inflammatory activities.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Anti-inflammatory</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Exosomes</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Hypoxia</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Interleukin-1β</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">hWJ-MSCs</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Tumor necrosis factor α</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>